MCRB - שווי שוק לנפח מכירות Seres Therapeutics Inc.

לוגו תאגידי של חברת Seres (MCRB)

Investments in a staff of top microbiologists support the price-to-sales ratio dynamics, where the 6.60 metric indicates the status of the current valuation for Seres Therapeutics (MCRB). Despite pressure from peers, Seres Therapeutics (MCRB) maintains its leadership as an industry pioneer. Risks are minimized through strategic alliances with industry behemoths to ensure the global distribution of innovative anti-infective drugs.

Seres (MCRB): יחס מחיר להכנסות מ-04.07.2022 עד 15.11.2026

פילוחי מדדים ואנליטיקה של חברת serestherapeutics.com (MCRB)

- מחיר שוק ויעדי מחיר של אנליסטים:
ניתוח פונדמנטלי של החברה:MCRB, Seres Therapeutics, Inc.
מוצרים מיוצרים של Seres Therapeutics

Seres Therapeutics (MCRB) investments in environmental safety and production cleanup are impacting operating expenses, which is reflected in the company's market cap-to-revenue ratio. This ratio compares the business's market value to its actual revenue, allowing investors to distinguish fundamental growth from a speculative bubble and determine the degree of overpayment for the asset based on this chart.